SUBSCRIBE
DONATE NOW
DONATE NOW

Topic: Uncategorized

Study of buprenorphine diversion cautions against its misuse

June 10th, 2022|

Buprenorphine is approved in many countries for the treatment of opioid use disorder (OUD), but problems with diversion and abuse exist. There is a need to understand how and why patients use diverted buprenorphine, and whether barriers to access contribute to illicit use.

58% reported a history of diverted buprenorphine use, with 37% never receiving a prescription. Approximately one-half (52%) reported using buprenorphine to get high or alter mood, but few (4%) indicated that it was their drug of choice.

The movement to expand methadone access to treat opioid addiction

May 6th, 2022|

Now officials at the Substance Abuse and Mental Health Services Administration are considering permanent changes to federal methadone rules. A National Academy of Medicine workshop on methadone regulations on March 3 and 4 may signal an inflection point.

Any changes to federal rules, however, could face significant resistance from methadone clinics — many of them for-profit — whose financial models are built on daily patient encounters, counseling, and regular drug tests. “There are some entities who have a financial interest in keeping things the way that they are,” Ryan said. “Change costs money.”

Research Identifies Pain Manage­ment Strategy That Reduces Opioid Exposure

January 29th, 2021|

SUBSCRIBE DONATE NOW Search Posts and/or Pages DONATE NOW Date:      |     Contributor:   Source:  ( )     |     Category: Summary and Analysis... Another study indicating that non-opioid solutions for pain management can be effective, i.e. opioids do not need to be the first line approach to pain management. Information such as this, had it been widely available and implemented, could have helped avoid the problems

Biden Admin to Halt Plans to Nix X-Waiver Require­ment

January 28th, 2021|

SUBSCRIBE DONATE NOW Search Posts and/or Pages DONATE NOW Date:      |     Contributor:   Source:  ( )     |     Category: Summary and Analysis... The new administration appears to be taking a different tact from the previous administration when it comes to rules related to the distribution of buprenorphine. According to the article, in the closing days of the Trump administration, guidelines were published that would have loosened

Is There A Big Pharma Fox In The Anti-Addiction Hen House?

March 13th, 2019|

The American Society of Addiction Medicine (ASAM) was founded in 1954 to study and improve the use of addictive substances in health care. In the half-century since, it has become a leading voice in the medical community with important reach into legislative and regulatory initiatives to abate the abuse of addictive drugs. Although it casts itself as an impartial organization, there are reasons to question whether the pharmaceutical industry has undue influence that may affect the organization’s advice. In recent years, a former president and the current president of ASAM have come under scrutiny for ties to big pharma. Dr.

Natural recoverers kick addiction without help

February 11th, 2019|

A few years ago, a friend of mine decided to quit smoking. She didn’t follow any pre-set plan, like Nicotine Anonymous, or do any research. Instead, she just quit. She also took up running, and around the same time started dating someone new—someone who didn’t smoke. She’s been cigarette-free ever since. We tend to think that stopping an addictive behavior means joining a group, seeing a therapist, going to a treatment center, or taking a medication that helps with cravings. It may come as a surprise to you—it certainly surprised me—that some people break addictions without any help. It turns

Go to Top